Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000921895-25-001601·BIOTECHNOLOGY VALUE FUND L P
Schedule 13D ownership disclosure
XOMA Royalty Corp
Common Stock, $0.0075 par value · CUSIP: 98419J206
Event date: 2025-05-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L PReported CIK 0000918923
Shares: 1,322,758.00 · Class: 11.1%
- BVF I GP LLCReported CIK 0001803805
Shares: 1,322,758.00 · Class: 11.1%
- BIOTECHNOLOGY VALUE FUND II LPReported CIK 0001102444
Shares: 1,267,545.00 · Class: 10.6%
- BVF II GP LLCReported CIK 0001803806
Shares: 1,267,545.00 · Class: 10.6%
- Biotechnology Value Trading Fund OS LPReported CIK 0001660683
Shares: 0.00 · Class: 0%
- BVF Partners OS Ltd.Reported CIK 0001660684
Shares: 0.00 · Class: 0%
- BVF GP HOLDINGS LLCReported CIK 0001803809
Shares: 2,590,303.00 · Class: 21.6%
- BVF PARTNERS L P/ILReported CIK 0001055947
Shares: 2,590,303.00 · Class: 21.6%
- BVF INC/ILReported CIK 0001056807
Shares: 2,590,303.00 · Class: 21.6%
- LAMPERT MARK NReported CIK 0001233840
Shares: 2,590,303.00 · Class: 21.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-001601
- Form type
- SCHEDULE 13D/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- May 20, 2025
- Reporting period
- May 16, 2025
- Description
- Schedule 13D beneficial ownership